Organon & Co. (OGN)
13.64
+0.01
(+0.07%)
USD |
NYSE |
Sep 11, 16:00
13.64
0.00 (0.00%)
After-Hours: 20:00
Organon Enterprise Value : 11.00B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 11.00B |
| September 10, 2026 | 11.00B |
| September 09, 2026 | 11.01B |
| September 08, 2026 | 11.03B |
| September 04, 2026 | 11.04B |
| September 03, 2026 | 11.04B |
| September 02, 2026 | 11.04B |
| September 01, 2026 | 11.03B |
| August 31, 2026 | 11.03B |
| August 28, 2026 | 11.03B |
| August 27, 2026 | 11.03B |
| August 26, 2026 | 11.04B |
| August 25, 2026 | 11.03B |
| August 24, 2026 | 11.03B |
| August 21, 2026 | 11.03B |
| August 20, 2026 | 11.03B |
| August 19, 2026 | 11.03B |
| August 18, 2026 | 11.01B |
| August 17, 2026 | 11.02B |
| August 14, 2026 | 11.02B |
| August 13, 2026 | 11.02B |
| August 12, 2026 | 11.01B |
| August 11, 2026 | 11.01B |
| August 10, 2026 | 11.00B |
| August 07, 2026 | 10.99B |
| Date | Value |
|---|---|
| August 06, 2026 | 10.98B |
| August 05, 2026 | 10.98B |
| August 04, 2026 | 10.98B |
| August 03, 2026 | 10.98B |
| July 31, 2026 | 10.98B |
| July 30, 2026 | 10.98B |
| July 29, 2026 | 10.98B |
| July 28, 2026 | 10.97B |
| July 27, 2026 | 10.98B |
| July 24, 2026 | 10.97B |
| July 23, 2026 | 10.98B |
| July 22, 2026 | 10.97B |
| July 21, 2026 | 10.97B |
| July 20, 2026 | 10.96B |
| July 17, 2026 | 10.97B |
| July 16, 2026 | 10.96B |
| July 15, 2026 | 10.96B |
| July 14, 2026 | 10.97B |
| July 13, 2026 | 10.97B |
| July 10, 2026 | 10.97B |
| July 09, 2026 | 10.96B |
| July 08, 2026 | 10.96B |
| July 07, 2026 | 10.97B |
| July 06, 2026 | 10.98B |
| July 02, 2026 | 10.98B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Merck & Co., Inc. | 402.09B |
| Eli Lilly & Co. | 1.096T |
| Pfizer Inc. | 209.77B |
| Bristol Myers Squibb Co. | 164.00B |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | 7.830B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 108.00M |
| Revenue (Quarterly) | 1.558B |
| Total Expenses (Quarterly) | 1.45B |
| EPS Diluted (Quarterly) | 0.3993 |
| Gross Profit Margin (Quarterly) | 54.36% |
| Profit Margin (Quarterly) | 6.93% |
| Earnings Yield | 5.72% |
| Operating Earnings Yield | 33.08% |
| Normalized Earnings Yield | 11.10 |